Roche’s Inavolisib Receives Breakthrough Designation for Advanced Breast Cancer Treatment

The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with pa...

May 21, 2024 | Tuesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity

Genentech, a member of the Roche Group  announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being...

May 16, 2024 | Thursday | News
OmniAb, Inc. Showcases Breakthrough in Antibody Discovery at PEGS Boston Summit

OmniAb, Inc. announced its participation in the 20th Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omn...

May 16, 2024 | Thursday | News
Atraverse Medical's HOTWIRE™ RF Guidewire Receives FDA Clearance, Revolutionizing Left-Heart Access

Atraverse Medical, a San Diego-based medical device company, announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel devic...

May 15, 2024 | Wednesday | News
Moderna's Investigational RSV Vaccine Review Delayed by FDA

Moderna, Inc. received notification from the U.S. Food and Drug Administration (FDA) regarding a delay in the review process for its investigational respir...

May 13, 2024 | Monday | News
Revance Launches DAXXIFY® for Cervical Dystonia Treatment in U.S. Market

This innovative therapy, the first and only peptide-formulated, long-lasting neurotoxin of its kind, presents a compelling option for patients and physicia...

May 13, 2024 | Monday | News
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine

  Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...

May 10, 2024 | Friday | News
ArkeaBio™ Secures $26.5 Million Series A Funding to Develop Paradigm-Shifting Livestock Methane Reduction Vaccine

ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, announced the close of a $26.5 million Series A ...

May 09, 2024 | Thursday | News
MSD Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global materna...

May 09, 2024 | Thursday | News
QIAGEN and FBI Join Forces to Pioneer Digital PCR Assay for QIAcuity in Forensic Applications

QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for i...

May 08, 2024 | Wednesday | News
CytomX Therapeutics Collaborates with MSD for First-in-Human Trial of Novel CX-801 Cytokine to Revolutionize Cancer Treatment

- CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform - - Phase 1 first-i...

May 08, 2024 | Wednesday | News
BrightInsight Teams Up with Google Cloud to Transform Patient Care with Advanced AI Solutions

BrightInsight, Inc, the trusted partner and platform driving value for top biopharma compliant digital health solutions, announced today that it will deplo...

May 07, 2024 | Tuesday | News
Walgreens and Boehringer Ingelheim Forge Strategic Partnership to Democratize Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusiv...

May 03, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in